StockData
Kazia Therapeutics Ltd logo

Kazia Therapeutics Ltd (KZIA) stock

KZIANasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Nov 17, 2026Score 1/30
$5.49+0.18 (+3.39%)

Close on Nov 18, 2026Market cap $8.89MP/E –Yield –

Kazia Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

For fiscal 2025 it was -49290.5%, against -1160.2% the year before. The highest annual figure on record is -55.5% in fiscal 2021.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Jun 30, 2025-49290.5%−48130.3
FY2024Jun 30, 2024-1160.2%−1104.8
FY2021Jun 30, 2021-55.5%+5019.3
FY2018Jun 30, 2018-5074.8%−789.6
FY2017Jun 30, 2017-4285.1%−1314.0
FY2016Jun 30, 2016-2971.2%–

More Kazia Therapeutics figures

See a number that looks wrong?